March 28th is Brain Tumour Research’s annual “Wear a Hat Day”, part the UK’s #BrainTumourAwarenessMonth. Novocure is a proud sponsor of #WearAHatDay and is joining others across the UK who will wear their favourite hats at work, in school or with friends and family. We hope you will consider supporting this initiative dedicated to raising awareness for brain tumours in the UK and the impact of these cancers on patients and their families. Learn more and wear a hat today to show your support: https://lnkd.in/gQ4_f3DM #BrainCancer #WeAreNovocure #PatientForward
Novocure
Herstellung medizinischer Geräte
Zug, Switzerland 56.743 Follower:innen
Patient-forward: Aspiring to make a difference in cancer
Info
We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer. Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.
- Website
-
http://www.novocure.com
Externer Link zu Novocure
- Branche
- Herstellung medizinischer Geräte
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zug, Switzerland
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2000
- Spezialgebiete
- Medical Device, Oncology, Cancer, Glioblastoma und Neuro-Oncology
Orte
Beschäftigte von Novocure
Updates
-
The Novocure team is at the European Lung Cancer Congress (ELCC) 2025 in Paris. If you are attending #ELCC25, visit the Novocure booth No. 100 in Pavilion 7 – Level 7.3, to learn about our innovative Tumor Treating Fields therapy. At Novocure, we are working to extend survival in some of the most aggressive forms of cancer, including lung cancer.
-
-
This week, NH Life Sciences (NHLS) hosted its roundtable event with New Hampshire Governor Kelly Ayotte at Novocure’s North American Flagship office in the heart of downtown Portsmouth. We are proud to be part of the NHLS and the growing life sciences community here in New Hampshire.
-
-
In recognition of International Women's Day 2025, our CEO Ashley Cordova shared an inspiring personal perspective.
Last year on #InternationalWomensDay, I shared a post about the role model my grandmother was for me. She built a successful Tupperware franchise and through her work I was able to observe her approach to business, team building and mentorship. I took a different career path than my grandmother, but the lessons I learned from her still serve me well, especially as I look back and recognize the challenges of starting and building a business as a woman. Her drive and determination are things I deeply admire, but I have grown to appreciate her courage in taking risks to pursue her goals. My path to being named CEO was not a traditional one, and it involved taking thoughtful risks at several points in my career. Risk taking is not always an easy thing to do, but we can learn to become more comfortable with it. Calculating risk is a skill I encourage people to develop because this is a way to understand our personal tolerance for the potential outcomes of our decisions. We all have degrees of tolerance for risks, but we don’t always challenge that tolerance when the rewards may be great. These are missed opportunities. Below are a few resources I have found inspiring and helpful when developing comfort with risk-taking. I'd love to hear your favorite resources in the comments - please share! 💡 Jenny Just and Poker Power teach women critical life skills, including risk-taking, through the game of poker at https://www.pokerpower.com 💡 Tim Ferriss talks about fear setting, a wonderfully useful way to frame risks and oppportunities, at https://lnkd.in/ewkXexGY 💡 Indra Nooyi shares her "risky" decision to shift PepsiCo's strategy toward healthier products in her book, a favorite of mine, at https://lnkd.in/eF94n8En In my role, I hope to be a resource for those who want to #AccelerateAction and deliver on the vision International Women's Day 2025 was founded to support: “a gender equal world. A world free of bias, stereotypes, and discrimination. A world that's diverse, equitable, and inclusive. A world where difference is valued and celebrated”. This remains a work in progress and may at times require risk taking to achieve, but it is a goal I am committed to pursuing.
-
Novocure announced today that management will participate in the Leerink Partners 2025 Global Healthcare Conference on Tuesday, March 11, 2025. Christoph Brackmann, Chief Financial Officer, will take part in a fireside chat at 4:20 p.m. EST, as well as one-on-one meetings with investors throughout the event. For more information, read the press release: https://lnkd.in/dVRddniq
-
-
Today, Novocure announced its financial results for the quarter and full year that ended December 31, 2024. For more information, read the press release: https://lnkd.in/d5ciGJkP
-
-
Today, Novocure announced its financial results for the quarter and full year that ended December 31, 2024. For more information, read the press release: https://lnkd.in/d5ciGJkP
-
-
Novocure hat dies direkt geteilt
Novocure turns 25! On February 11, 2000, Professor Yoram Palti, M.D., Ph.D., founded Novocure, based on the innovative idea that electric fields at very specific frequencies could be harnessed to treat cancer. Today this approach is known as Tumor Treating Fields therapy, and has been used to treat more than 35,000 patients. Novocure is now a global oncology company, with more than 1,400 passionate, talented and caring employees working to deliver on our patient-forward mission. We are grateful for everyone who joined us on this journey so far and we look forward to the way ahead. Please join us in celebrating our 25-year anniversary! #WeAreNovocure #patientforward
-
-
Novocure turns 25! On February 11, 2000, Professor Yoram Palti, M.D., Ph.D., founded Novocure, based on the innovative idea that electric fields at very specific frequencies could be harnessed to treat cancer. Today this approach is known as Tumor Treating Fields therapy, and has been used to treat more than 35,000 patients. Novocure is now a global oncology company, with more than 1,400 passionate, talented and caring employees working to deliver on our patient-forward mission. We are grateful for everyone who joined us on this journey so far and we look forward to the way ahead. Please join us in celebrating our 25-year anniversary! #WeAreNovocure #patientforward
-
-
Today, Ashley Cordova, Novocure’s CEO, rang the Nasdaq opening bell in celebration of our 25-year anniversary. Novocure was honored to be joined by several patients and family members as well as leadership from the Musella Foundation, American Brain Tumor Association, StacheStrong, Let's Win Pancreatic Cancer and the American Association for Cancer Research.
-
Ähnliche Seiten
Aktien
NVCR
NASDAQ
Verzögerung von 20 Minuten
18,86 $
-0,11 (-0,58 %)
- Aktiv
- 18,93
- Niedrig
- 18,405
- Hoch
- 18,93
Daten von Refinitiv
Mehr Informationen aufFinanzierung
Novocure
Insgesamt 7 Finanzierungsrunden
![]()
Pharmakon Advisors
Weitere Informationen auf Crunchbase
Letzte Runde
Fremdkapital nach Börsengang
Externer Crunchbase-Link für die letzte Finanzierungsrunde
100.000.000,00 $
Investor:innen